AL-60371 Otic Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-60371 Otic Suspension, covering 2013-12-10 to 2013-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa [Phase 3]